VEROVACCiNES GmbH

VEROVACCiNES develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industry's need for - cost effective vaccines - reduce immunization effort - reduced use of antibiotics A recent development allows to combine several antigens (immunity generating substances) in an single vaccine without increasing production costs. This allows e.g. to target different pathogens with a single vaccine or to generate broad band vaccines targeting immunity evading variants of the same pathogen. The company has a pipeline of 5 vaccine programs at various developmental stages. Four of these programs have already been validated (proof of concept). Several candidates have blockbuster potential. We are developing vaccine solutions for poultry, swine and ruminants. VEROVACCiNES is engaged in collaborations with market leaders as well as with academic institutions.